Does educational printed material manage to change compliance with prostate cancer screening?

World Journal of Urology

Volumn 26, Issue 4, 2008, Pages 365-373

  Stamatiou, Konstantinos ^a,d,e   Skolarikos, Andreas ^b   Heretis, Ioannis ^c   Papadimitriou, Vaios ^c   Alevizos, Alevizos ^d   Ilias, Georgios ^a   Karanasiou, Vasilissa ^a   Mariolis, Anargiros ^d   Sofras, Frank ^c  

^a General Hospital of Thebes   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

^d Health Center of Vyronas   (Greece)

^e NONE   (Greece)

Author keywords

Patient education; Patient information systems

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HEALTH BEHAVIOR; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; PUBLICATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; DIGITAL RECTAL EXAMINATION; HEALTH BEHAVIOR; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PAMPHLETS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 50249120142     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-008-0258-z     Document Type: Article

References (47)

1. Silva JS, Zawilski AJ (1992) The health care professional's workstation: its functional components and user impact. In: Ball MJ, Collen MF (eds) Aspects of the computer-based patient record. Springer, New York, pp 103-123
2. No author listed (1996) Guide to clinical preventive services, 2nd edn. Report of the US Preventive Services Task Force. Williams & Wilkins, Baltimore, pp 119-34
3. Boling W, Laufman L, Lynch GR, Weinberg AD (2005) Increasing mammography screening through inpatient education. J Cancer Educ 20(4):247-250
4. Webster P, Austoker J (2007) Does the english breast screening programme's information leaflet improve women's knowledge about mammography screening? A before and after questionnaire survey. J Public Health (Oxf) 29(2):173-177
5. Franceschi S (2005) The IARC commitment to cancer prevention: The example of papillomavirus and cervical cancer. Recent Results Cancer Res 166:277-297
6. Osterling JE (1996) Early detection of prostate cancer. Decreasing the mortality rate. Minn Med 79:46-9
7. Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK (1993) Prostate cancer screening: What we know and what we need to know. Ann Intern Med 119:914-923
8. Woolf HS (1995) Screening for prostate cancer with prostate-specific antigen: An examination of evidence. N Engl J Med 333:1401-1405
9. Krist A, Woolf S, Johnson R, Kerns W (2007) Patient education on prostate cancer screening and involvement in decision making. Ann Fam Med 5(2):112-119
10. Frosch DL, Kaplan RM, Felitti VJ (2003) A randomized controlled trial comparing Internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med 18(10):781-787
11. Auvinen A, Calais Da Silva F, Denis LJ, Hugosson J, Schroeder F (1996) The European Randomised Study for Prostate Cancer (ERSPC). International Cooperation and Preliminary Data. Parthenon, New York, pp 167-172
12. No author listed (1999) The International Prostate Screening Trial Evaluation Group. Rationale for randomised trials of prostate cancer screening. Eur J Cancer 35:262-271
13. de Koning HJ, Auvinen A, Berenguer-Sanchez A et al (2002) Large-scale randomized prostate cancer screening trials; program performance in the ERSPC and PLCO trials. Int J Cancer 97:237-244
14. de Koning HJ, Liem MK, Baan CA, Boer R, Schroder FH, Alexander FE, ERSPC (2002) Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial. Int J Cancer 98:268-273
15. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK (2000) Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21:273S-309S
16. Harris R, Lohr KN (2002) Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:917-929
17. Graif T, Yu X, Loeb S (2006) Underdiagnosis and overdiagnosis of prostate cancer. Program and abstracts of the American Urological Association 2006 Annual Meeting; May 20-25, Atlanta, Georgia, Abstract 476
18. Oliffe J (2006) Being screened for prostate cancer: A simple blood test or a commitment to treatment? Cancer Nurs 2006 04/
19. Deliveliotis C, Alivizatos G, Karayiannis A, Kontothanasis D, Makrychoritis K, Lysiotis P, Dimopoulos MA (1995) The value of prostatic specific antigen in the early diagnosis of prostatic cancer: A Greek view. Br J Urol 75(5):637-641
20. Stamatiou K, Alevizos A, Agapitos E, Sofras F (2006) Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: An autopsy study. Prostate;2006:10; [Epub ahead of print]
21. No author listed. Agency for Healthcare Research and Quality "The Guide to Clinical Preventive Services 2005: Recommendations of the U.S. Preventive Services Task Force." 2005
22. Advisory Committee on Cancer Prevention (2000) Position paper. Recommendations on cancer screening in European Union. Eur J Cancer 36:1473-1478
23. Holund B (1980) Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol 14:29-43
24. Haggerty J, Tudiver F, Brown JB, Herbert C, Ciampi A, Guibert R (2005) Patients' anxiety and expectations. How they influence family physicians' decisions to order cancer screening tests. Can Fam Physician 51(12):1659
25. Constantinou J, Feneley MR (2006) PSA testing: An evolving relationship with prostate cancer screening. Prostate Cancer Prostatic Dis 9:6-13
26. Bowersox J (1992) American Cancer Society adopts new prostate cancer screening guidelines. J Natl Cancer Inst 84:1856-1857
27. Mettlin C, Jones GW, Averette H, Gusberg SB, Murphy GP (1993) Defining and updating the American Cancer Society guidelines for the cancer related checkup: Prostate and endometrial cancer. Cancer J Clin 43:42-46
28. Weinrich SP, Wienrich MC, Boyd MD, Atkinson C (1998) The impact of prostate cancer knowledge on cancer screening. Oncol Nurs Forum 25:527-34
29. Abbott R, Taylor DK, Barber K (1998) A comparison of prostate knowledge of African American and Caucasian men: Changes from prescreening baseline to postintervention. Cancer J 4:175
30. Weinrich SP, Boyd MD, Weinrich M, Greene F, Reynolds WA Jr, Metlin C (1998) Increasing prostate cancer screening in African American men with peer-educator and client-navigator interventions. J Cancer Educ 13(4):213-219
31. Davison BJ, Kirk P (1999) Information and patient participation in screening for prostate cancer. Patient Educ Couns 37(3):255-263
32. Lewis D (1999) Computer-based approaches to patient education: A review of the literature. J Am Med Inform Assoc 6:272-282
33. Hammond CS, Wasson JH et al (2001) A frequently used patient and physician-directed educational intervention does nothing to improve primary care of prostate conditions. Urology 58(6):875-881
34. Weinrich SP, Seger R, Miller BL, Davis C, Kim S, Wheeler C, Weinrich M (2004) Knowledge of the limitations associated with prostate cancer screening among low-income men. Cancer Nurs 27(6):442-453
35. Lockman AR (2001) Does the manner in which information about prostate-specific antigen (PSA) testing is presented affect screening rates? Jour Fam Pract 50(10):898
36. Frosch DL, Kaplan RM, Felitti VJ (2003) A randomized controlled trial comparing Internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med 18(10):781-787
37. Tingen M, Weinrich S, Heydt D, Boyd M, Weinrich M (1998) Perceived benefits: A predictor of participation in prostate cancer screening. Cancer Nurs 21:349-357
38. Van Den Eeden S, Enger S, Caan B (2003) Predictors of having a PSA test (abstract). Am J Epidemiol 157:aBstract 368
39. Steenland K Rodriguez C, Mondul A, Calle E, Thun M (2004) Prostate cancer incidence and survival in relation to education. Cancer Causes Control 15:939-945
40. Kripalani S, Sharma J, Justice E, Justice J, Spiker C, Laufman LE, Jacobson TA, Weinberg AD (2005) Prostate cancer screening in a low-literacy population: Does informed decision making occur? Cancer C Control 12(2):116-117
41. Myers RE, Hyslop T, Wolf TA, Burgh D, Kunkel EJ, Oyesanmi OA, Chodak GJ (2000) African-American men and intention to adhere to recommended follow-up for an abnormal prostate cancer early detection examination result. Urology 55(5):716-720
42. Schapira MM, VanRuiswyk J (2000) The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract 49(5):418-24
43. Flood AB, Wennberg JE et al (1996) The importance of patient preference in the decision to screen for prostate cancer. Prostate patient outcomes research team. J Gen Intern Med 11(6):342
44. Kripalani S, Sharma J, Justice E, Justice J, Spiker C, Laufman LE, Price M, Weinberg AD (2007) Low-literacy interventions to promote discussion of prostate cancer: A randomized controlled trial. Am J Prev Med 33(2):83-90
45. Philip J, Dutta Roy S, Viswanathan P (2006) Digital rectal examination is a barrier to population-based prostate cancer screening. Urology 67(3):655
46. Mistry K, Cable G (2003) Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. J Am Board Fam Pract 16(2):95-103
47. Pruthi RS, Tornehl C, Gaston K, Lee K, Moore D, Carson CC, Wallen EM (2006) Impact of race, age, income, and residence on prostate cancer knowledge, screening behavior, and health maintenance in siblings of patients with prostate cancer. Eur Urol 50:64-69